Lee CY, Wang WF, Hsu JL, Yang YH, Jhang KM. A 52-week, open-label, observational study evaluating tolerability, efficacy and physicians satisfaction of rivastigmine oral solution in Alzheimer's disease in Taiwan. J Alzheimers Dis Rep. 2025;9:25424823241311860. Epub 2025 Jan 15 PubMed.
Recommends
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.